Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,633
Closed -$66.7K 371
2025
Q1
$66.7K Buy
+2,633
New +$68.9K 0.02% 139
2024
Q4
Sell
-2,633
Closed -$76.2K 162
2024
Q3
$76.2K Sell
2,633
-1,134
-30% -$33.1K 0.03% 110
2024
Q2
$105K Sell
3,767
-1,667
-31% -$45.9K 0.05% 95
2024
Q1
$151K Sell
5,434
-301
-5% -$8.35K 0.07% 82
2023
Q4
$165K Sell
5,735
-5,800
-50% -$175K 0.15% 71
2023
Q3
$530K Buy
11,535
+4,068
+54% +$144K 0.27% 53
2023
Q2
$274K Hold
7,467
0.14% 74
2023
Q1
$305K Sell
7,467
-2,036
-21% -$87.9K 0.16% 73
2022
Q4
$459K Buy
9,503
+4
+0% +$192 0.27% 67
2022
Q3
$392K Sell
9,499
-745
-7% -$36.2K 0.25% 72
2022
Q2
$509K Buy
10,244
+4
+0% +$204 0.26% 71
2022
Q1
$488K Buy
10,240
+523
+5% +$27.1K 0.22% 76
2021
Q4
$574K Hold
9,717
0.23% 79
2021
Q3
$418K Sell
9,717
-300
-3% -$13.3K 0.18% 82
2021
Q2
$392K Sell
10,017
-800
-7% -$31.1K 0.17% 90
2021
Q1
$392K Sell
10,817
-400
-4% -$14.2K 0.19% 89
2020
Q4
$413K Sell
11,217
-606
-5% -$22.2K 0.23% 83
2020
Q3
$412K Hold
11,823
0.28% 78
2020
Q2
$367K Hold
11,823
0.37% 69
2020
Q1
$366K Sell
11,823
-4,131
-26% -$141K 0.4% 72
2019
Q4
$593K Sell
15,954
-1,105
-6% -$39.4K 0.52% 62
2019
Q3
$582K Sell
17,059
-1,209
-7% -$44K 0.58% 60
2019
Q2
$751K Sell
18,268
-314
-2% -$12.5K 0.79% 52
2019
Q1
$749K Sell
18,582
-156
-0.8% -$6.25K 0.81% 50
2018
Q4
$776K Buy
+18,738
New +$778K 0.96% 46

Other funds holding PFE

DAGCO Inc's PFE Position: Q2 2025 in Review

DAGCO Inc sold out of Pfizer (PFE) in Q2 2025, closing a stake of 2,633 shares — an estimated $66.7K sold.

DAGCO Inc first reported a position in PFE in Q4 2018 and held it in 25 quarters. The position peaked at $776K in Q4 2018. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • DAGCO Inc reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • DAGCO Inc sold 2,633 Pfizer shares in Q2 2025, an estimated $66.7K.
  • DAGCO Inc first reported a position in Pfizer in Q4 2018 and held it in 25 quarters.
  • DAGCO Inc's Pfizer position peaked at $776K in Q4 2018.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on DAGCO Inc's 13F filing for Q2 2025, filed 14 Aug 2025.